Skip to main content

Ethicon Prolene Hernia Patch Lawsuit Filed in New Jersey

Ethicon Prolene Hernia Patch Lawsuit Filed in New Jersey

Ethicon Prolene Hernia Patch Lawsuit Filed in New Jersey

Introduction

A lawsuit filed by a plaintiff in the New Jersey Supreme Court against Ethicon Prolene manufacturer Johnson & Johnson and its subsidiary Ethicon, alleges that the hernia patch led to a series of complications ever since it was implanted.

The complaint filed by the plaintiff on July 5 indicates that he was implanted with a 4.5 cm by 10 cm patch of the Ethicon Prolene Hernia System February 2007, for correcting a right inguinal hernia. Surgeons discovered that the Prolene Hernia Mesh got attached to the inguinal canal floor and encircled his spermatic cord as well as the iliac inguinal nerve. The condition worsened as he developed severe pain, inflammation, nausea, extreme weight loss, and the need for additional surgeries. Eventually, he underwent revision surgery to remove the hernia patch in December 2009. The lawsuit states Johnson & Johnson and Ethicon did not conduct proper clinical trials for their Ethicon multi-layered hernia mesh product line, which includes the Prolene Hernia System, as well as the recalled Physiomesh product.  

Hernia Mesh Lawsuits were consolidated in June 2017 for pretrial proceedings in the Northern District of Georgia as a part of a multidistrict litigation (MDL No. 2782; In Re: Ethicon Physiomesh Flexible Composite Hernia Mesh Products Liability Litigation) presided over by Judge Richard Story.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

NC to Get $150M to Boost Opioid Treatment, Recovery

Categories: Opioids

North Carolina will receive an additional $150 million from Purdue Pharma and the Sackler family as part of a national $7.4 billion settlement related to the opioid

SRI Gets FDA OK for High-Dose Naloxone Trial

Categories: Opioids

SRI has received authorization from the U.S. Food and Drug Administration (FDA) to begin Phase 1 clinical trials of a new, high-dose injectable naloxone formulation.

The approval was granted under an Investigational New Drug (IND)…

Spokane County to Get $5M in New Opioid Settlement

Categories: Opioids

Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.

The agreement addresses the company’s role in fueling…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!